Award
NIH Reporter #5R01CA273224-05
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Recipient
Not specified
Award Amount
$734,405.00
Ceiling
$734,405.00
Awarded
July 01, 2026
Identifier
5R01CA273224-05
NIH awarded a grant to support research integrating imaging and plasma cell-free DNA sequencing to monitor treatment response and predict cancer progression in patients undergoing targeted therapy.
Description
This NIH grant supports research on integrating advanced imaging and plasma circulating tumor DNA biomarkers to improve cancer treatment response assessment and personalized medicine approaches.